AGL 40.01 Decreased By ▼ -0.01 (-0.02%)
AIRLINK 187.98 Increased By ▲ 9.91 (5.57%)
BOP 10.12 Increased By ▲ 0.16 (1.61%)
CNERGY 7.11 Increased By ▲ 0.17 (2.45%)
DCL 10.15 Increased By ▲ 0.06 (0.59%)
DFML 41.57 No Change ▼ 0.00 (0%)
DGKC 107.91 Increased By ▲ 1.02 (0.95%)
FCCL 39.00 Decreased By ▼ -0.03 (-0.08%)
FFBL 82.02 Increased By ▲ 0.13 (0.16%)
FFL 14.90 Increased By ▲ 1.20 (8.76%)
HUBC 119.46 Increased By ▲ 0.21 (0.18%)
HUMNL 14.05 Increased By ▲ 0.05 (0.36%)
KEL 6.40 Increased By ▲ 0.49 (8.29%)
KOSM 8.07 Increased By ▲ 0.01 (0.12%)
MLCF 49.47 Increased By ▲ 1.37 (2.85%)
NBP 73.66 Increased By ▲ 0.83 (1.14%)
OGDC 204.85 Increased By ▲ 11.09 (5.72%)
PAEL 33.56 Increased By ▲ 1.41 (4.39%)
PIBTL 8.07 Increased By ▲ 0.05 (0.62%)
PPL 185.41 Increased By ▲ 11.34 (6.51%)
PRL 33.61 Increased By ▲ 1.01 (3.1%)
PTC 27.39 Increased By ▲ 2.12 (8.39%)
SEARL 119.82 Decreased By ▼ -5.14 (-4.11%)
TELE 9.69 Increased By ▲ 0.27 (2.87%)
TOMCL 35.30 Decreased By ▼ -0.09 (-0.25%)
TPLP 12.25 Increased By ▲ 0.63 (5.42%)
TREET 20.26 Increased By ▲ 1.84 (9.99%)
TRG 60.78 Increased By ▲ 0.29 (0.48%)
UNITY 37.99 Decreased By ▼ -0.22 (-0.58%)
WTL 1.65 Decreased By ▼ -0.01 (-0.6%)
BR100 11,772 Increased By 249.2 (2.16%)
BR30 36,584 Increased By 1034.2 (2.91%)
KSE100 110,810 Increased By 1913.6 (1.76%)
KSE30 34,429 Increased By 620.5 (1.84%)
World

Germany says does not intend to delay second COVID-19 vaccine shot

  • Germany has asked an independent expert panel for advice on whether to allow a delay in administering the second dose to make scarce supplies go further.
  • My impression is that it makes a lot of sense, especially with these sensitive issues, where trust and reliability are important.
Published January 6, 2021

BERLIN: Germany intends to stick to recommendations by BioNTech and Pfizer regarding the administration of a second dose of their COVID-19 vaccines rather than delaying it, Health Minister Jens Spahn said on Wednesday.

Germany has asked an independent expert panel for advice on whether to allow a delay in administering the second dose to make scarce supplies go further, after a similar move by Britain last week.

"My impression is that it makes a lot of sense, especially with these sensitive issues, where trust and reliability are important, that we stick to the approval," Spahn told a news conference, adding that this was in line with the initial feedback he had received from the vaccination experts.

He also spoke out against mixing or switching between COVID-19 vaccines, which some nations are also considering to stretch scarce supplies.

Germany's 83 million residents will receive more than 130 million COVID-19 vaccine doses, enough for everybody who needs to receive the shots, Spahn said.

He said that he expects first deliveries of the vaccine developed by Moderna next week. The European Medicines Agency earlier on Wednesday approved the US drugmaker's vaccine for emergency use.

Germany will receive 50 million doses of the Moderna vaccine this year, of which 2 million doses are expected in the first quarter, he said.

Comments

Comments are closed.